I think this is the issue with profitability of this tech. EIQ will get FDA approval based on this, but I wonder if the big medical device manufacturers will just bundle their own AI with their devices, making it less likely to command a premium price for a third party provider like EIQ. The device manufacturers will also have massive databases of echocardiograms.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $154.8M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 24.0¢ | $225.8K | 879.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 284489 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 26866 | 7 |
View Market Depth
| Last trade - 12.23pm 03/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |